List of Tables
Table 1. Global Neurological Biomarkers Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Neurological Biomarkers Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Neurological Biomarkers Market Competitive Situation by Manufacturers in 2022
Table 4. Global Neurological Biomarkers Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Neurological Biomarkers Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Neurological Biomarkers Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Neurological Biomarkers Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Neurological Biomarkers Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Neurological Biomarkers, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Neurological Biomarkers, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Neurological Biomarkers, Product Type & Application
Table 12. Global Key Manufacturers of Neurological Biomarkers, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Neurological Biomarkers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurological Biomarkers as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Neurological Biomarkers Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Neurological Biomarkers Sales by Region (2018-2023) & (K Units)
Table 18. Global Neurological Biomarkers Sales Market Share by Region (2018-2023)
Table 19. Global Neurological Biomarkers Sales by Region (2024-2029) & (K Units)
Table 20. Global Neurological Biomarkers Sales Market Share by Region (2024-2029)
Table 21. Global Neurological Biomarkers Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Neurological Biomarkers Revenue Market Share by Region (2018-2023)
Table 23. Global Neurological Biomarkers Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Neurological Biomarkers Revenue Market Share by Region (2024-2029)
Table 25. North America Neurological Biomarkers Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Neurological Biomarkers Sales by Country (2018-2023) & (K Units)
Table 27. North America Neurological Biomarkers Sales by Country (2024-2029) & (K Units)
Table 28. North America Neurological Biomarkers Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Neurological Biomarkers Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Neurological Biomarkers Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Neurological Biomarkers Sales by Country (2018-2023) & (K Units)
Table 32. Europe Neurological Biomarkers Sales by Country (2024-2029) & (K Units)
Table 33. Europe Neurological Biomarkers Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Neurological Biomarkers Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Neurological Biomarkers Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Neurological Biomarkers Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Neurological Biomarkers Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Neurological Biomarkers Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Neurological Biomarkers Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Neurological Biomarkers Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Neurological Biomarkers Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Neurological Biomarkers Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Neurological Biomarkers Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Neurological Biomarkers Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Neurological Biomarkers Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Neurological Biomarkers Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Neurological Biomarkers Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Neurological Biomarkers Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Neurological Biomarkers Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Neurological Biomarkers Sales (K Units) by Type (2018-2023)
Table 51. Global Neurological Biomarkers Sales (K Units) by Type (2024-2029)
Table 52. Global Neurological Biomarkers Sales Market Share by Type (2018-2023)
Table 53. Global Neurological Biomarkers Sales Market Share by Type (2024-2029)
Table 54. Global Neurological Biomarkers Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Neurological Biomarkers Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Neurological Biomarkers Revenue Market Share by Type (2018-2023)
Table 57. Global Neurological Biomarkers Revenue Market Share by Type (2024-2029)
Table 58. Global Neurological Biomarkers Price (USD/Unit) by Type (2018-2023)
Table 59. Global Neurological Biomarkers Price (USD/Unit) by Type (2024-2029)
Table 60. Global Neurological Biomarkers Sales (K Units) by Application (2018-2023)
Table 61. Global Neurological Biomarkers Sales (K Units) by Application (2024-2029)
Table 62. Global Neurological Biomarkers Sales Market Share by Application (2018-2023)
Table 63. Global Neurological Biomarkers Sales Market Share by Application (2024-2029)
Table 64. Global Neurological Biomarkers Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Neurological Biomarkers Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Neurological Biomarkers Revenue Market Share by Application (2018-2023)
Table 67. Global Neurological Biomarkers Revenue Market Share by Application (2024-2029)
Table 68. Global Neurological Biomarkers Price (USD/Unit) by Application (2018-2023)
Table 69. Global Neurological Biomarkers Price (USD/Unit) by Application (2024-2029)
Table 70. Thermo Fisher Scientific Corporation Information
Table 71. Thermo Fisher Scientific Description and Business Overview
Table 72. Thermo Fisher Scientific Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Thermo Fisher Scientific Neurological Biomarkers Product
Table 74. Thermo Fisher Scientific Recent Developments/Updates
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Merck Neurological Biomarkers Product
Table 79. Merck Recent Developments/Updates
Table 80. Quest Diagnostics Corporation Information
Table 81. Quest Diagnostics Description and Business Overview
Table 82. Quest Diagnostics Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Quest Diagnostics Neurological Biomarkers Product
Table 84. Quest Diagnostics Recent Developments/Updates
Table 85. Abbott Corporation Information
Table 86. Abbott Description and Business Overview
Table 87. Abbott Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Abbott Neurological Biomarkers Product
Table 89. Abbott Recent Developments/Updates
Table 90. Roche Corporation Information
Table 91. Roche Description and Business Overview
Table 92. Roche Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Roche Neurological Biomarkers Product
Table 94. Roche Recent Developments/Updates
Table 95. Illumina Corporation Information
Table 96. Illumina Description and Business Overview
Table 97. Illumina Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Illumina Neurological Biomarkers Product
Table 99. Illumina Recent Developments/Updates
Table 100. Bio-Rad Laboratories Corporation Information
Table 101. Bio-Rad Laboratories Description and Business Overview
Table 102. Bio-Rad Laboratories Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Bio-Rad Laboratories Neurological Biomarkers Product
Table 104. Bio-Rad Laboratories Recent Developments/Updates
Table 105. QIAGEN Corporation Information
Table 106. QIAGEN Description and Business Overview
Table 107. QIAGEN Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. QIAGEN Neurological Biomarkers Product
Table 109. QIAGEN Recent Developments/Updates
Table 110. Myriad RBM Corporation Information
Table 111. Myriad RBM Description and Business Overview
Table 112. Myriad RBM Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Myriad RBM Neurological Biomarkers Product
Table 114. Myriad RBM Recent Developments/Updates
Table 115. Cisbio Bioassays Corporation Information
Table 116. Cisbio Bioassays Description and Business Overview
Table 117. Cisbio Bioassays Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Cisbio Bioassays Neurological Biomarkers Product
Table 119. Cisbio Bioassays Recent Developments/Updates
Table 120. Athena Diagnostics Corporation Information
Table 121. Athena Diagnostics Description and Business Overview
Table 122. Athena Diagnostics Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Athena Diagnostics Neurological Biomarkers Product
Table 124. Athena Diagnostics Recent Developments/Updates
Table 125. BGI Corporation Information
Table 126. BGI Description and Business Overview
Table 127. BGI Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. BGI Neurological Biomarkers Product
Table 129. BGI Recent Developments/Updates
Table 130. Wuxi APP Corporation Information
Table 131. Wuxi APP Description and Business Overview
Table 132. Wuxi APP Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Wuxi APP Neurological Biomarkers Product
Table 134. Wuxi APP Recent Developments/Updates
Table 135. Aepodia Corporation Information
Table 136. Aepodia Description and Business Overview
Table 137. Aepodia Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Aepodia Neurological Biomarkers Product
Table 139. Aepodia Recent Developments/Updates
Table 140. Proteome Sciences Corporation Information
Table 141. Proteome Sciences Description and Business Overview
Table 142. Proteome Sciences Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. Proteome Sciences Neurological Biomarkers Product
Table 144. Proteome Sciences Recent Developments/Updates
Table 145. Genewiz Corporation Information
Table 146. Genewiz Description and Business Overview
Table 147. Genewiz Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 148. Genewiz Neurological Biomarkers Product
Table 149. Genewiz Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Neurological Biomarkers Distributors List
Table 153. Neurological Biomarkers Customers List
Table 154. Neurological Biomarkers Market Trends
Table 155. Neurological Biomarkers Market Drivers
Table 156. Neurological Biomarkers Market Challenges
Table 157. Neurological Biomarkers Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Neurological Biomarkers
Figure 2. Global Neurological Biomarkers Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Neurological Biomarkers Market Share by Type in 2022 & 2029
Figure 4. Proteomics Product Picture
Figure 5. Genomics Product Picture
Figure 6. Imaging Product Picture
Figure 7. Bioinformatics Product Picture
Figure 8. Others Product Picture
Figure 9. Global Neurological Biomarkers Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 10. Global Neurological Biomarkers Market Share by Application in 2022 & 2029
Figure 11. Diagnostics
Figure 12. Drug Discovery
Figure 13. Personalized Medicine
Figure 14. Others
Figure 15. Global Neurological Biomarkers Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Neurological Biomarkers Market Size (2018-2029) & (US$ Million)
Figure 17. Global Neurological Biomarkers Sales (2018-2029) & (K Units)
Figure 18. Global Neurological Biomarkers Average Price (USD/Unit) & (2018-2029)
Figure 19. Neurological Biomarkers Report Years Considered
Figure 20. Neurological Biomarkers Sales Share by Manufacturers in 2022
Figure 21. Global Neurological Biomarkers Revenue Share by Manufacturers in 2022
Figure 22. The Global 5 and 10 Largest Neurological Biomarkers Players: Market Share by Revenue in 2022
Figure 23. Neurological Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 24. Global Neurological Biomarkers Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 25. North America Neurological Biomarkers Sales Market Share by Country (2018-2029)
Figure 26. North America Neurological Biomarkers Revenue Market Share by Country (2018-2029)
Figure 27. U.S. Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Canada Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Europe Neurological Biomarkers Sales Market Share by Country (2018-2029)
Figure 30. Europe Neurological Biomarkers Revenue Market Share by Country (2018-2029)
Figure 31. Germany Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. France Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. U.K. Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Italy Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Russia Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Asia Pacific Neurological Biomarkers Sales Market Share by Region (2018-2029)
Figure 37. Asia Pacific Neurological Biomarkers Revenue Market Share by Region (2018-2029)
Figure 38. China Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Taiwan Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Indonesia Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Thailand Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Malaysia Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Philippines Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Latin America Neurological Biomarkers Sales Market Share by Country (2018-2029)
Figure 49. Latin America Neurological Biomarkers Revenue Market Share by Country (2018-2029)
Figure 50. Mexico Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Brazil Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Argentina Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Middle East & Africa Neurological Biomarkers Sales Market Share by Country (2018-2029)
Figure 54. Middle East & Africa Neurological Biomarkers Revenue Market Share by Country (2018-2029)
Figure 55. Turkey Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. U.A.E Neurological Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Global Sales Market Share of Neurological Biomarkers by Type (2018-2029)
Figure 59. Global Revenue Market Share of Neurological Biomarkers by Type (2018-2029)
Figure 60. Global Neurological Biomarkers Price (USD/Unit) by Type (2018-2029)
Figure 61. Global Sales Market Share of Neurological Biomarkers by Application (2018-2029)
Figure 62. Global Revenue Market Share of Neurological Biomarkers by Application (2018-2029)
Figure 63. Global Neurological Biomarkers Price (USD/Unit) by Application (2018-2029)
Figure 64. Neurological Biomarkers Value Chain
Figure 65. Neurological Biomarkers Production Process
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed